Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Apr;105(4):863–868. doi: 10.1111/j.1476-5381.1992.tb09069.x

Neuroendocrine response to clonidine and 8-OH-DPAT in rats following chronic administration of desipramine or sertraline.

J M O'Donnell 1, M Grealy 1
PMCID: PMC1908697  PMID: 1387021

Abstract

1. Rats were administered either desipramine (DMI) or sertraline daily at doses 7.5 mg kg-1 or 10 mg kg-1, i.p., respectively and the effects on the functional state of hypothalamic neuroendocrine control mechanisms assessed by measurements of plasma hormones following acute drug challenge. The effects of treatment on gross behaviour and brain adrenoceptor density were also determined. 2. Both DMI and sertraline caused significant reduction in activity measured as ambulation and rearing at 14 days of treatment. 3. All animals were chronically cannulated after 14 days of treatment and tested for neuroendocrine response to acute i.v. clonidine (50 micrograms kg-1) or 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT, 250 micrograms kg-1) after 21 or more days of treatment. 4. Rats treated with DMI but not sertraline showed a virtually complete suppression of the growth hormone (GH) secretion elicited by clonidine in controls, while the secretion of corticosterone was augmented. 5. Treatment with DMI but not sertraline led to a significantly greater 8-OH-DPAT-induced secretion of prolactin than in the control rats, while the plasma concentrations of corticosterone following 8-OH-DPAT were not influenced by either DMI or sertraline treatment. 6. The density (but not the affinity) of cerebral cortical binding of [3H]-dihydroalprenolol was significantly reduced by DMI treatment. 7. These results show that DMI treatment blunted the sensitivity of post-synaptic alpha 2-adrenoceptors, accompanied by complex interactions manifested as increased responsiveness of alpha 1-adrenoceptors and 5-HT1A receptors. Sertraline had no significant neurendocrine effects at a dose which significantly reduced gross activity.

Full text

PDF
863

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aulakh C. S., Wozniak K. M., Haas M., Hill J. L., Zohar J., Murphy D. L. Food intake, neuroendocrine and temperature effects of 8-OHDPAT in the rat. Eur J Pharmacol. 1988 Feb 9;146(2-3):253–259. doi: 10.1016/0014-2999(88)90300-7. [DOI] [PubMed] [Google Scholar]
  2. Aulakh C. S., Wozniak K. M., Hill J. L., Murphy D. L. Differential effects of long-term antidepressant treatments on 8-OHDPAT-induced increases in plasma prolactin and corticosterone in rats. Eur J Pharmacol. 1988 Nov 8;156(3):395–400. doi: 10.1016/0014-2999(88)90285-3. [DOI] [PubMed] [Google Scholar]
  3. Bylund D. B., Snyder S. H. Beta adrenergic receptor binding in membrane preparations from mammalian brain. Mol Pharmacol. 1976 Jul;12(4):568–580. [PubMed] [Google Scholar]
  4. Checkley S. A., Corn T. H., Glass I. B., Thompson C., Franey C., Arendt J. Neuroendocrine and other studies of the mechanism of antidepressant action of desipramine. Ciba Found Symp. 1986;123:126–147. doi: 10.1002/9780470513361.ch8. [DOI] [PubMed] [Google Scholar]
  5. Cohen R. M., Campbell I. C., Dauphin M., Tallman J. F., Murphy D. L. Changes in alpha- and beta-receptor densities in rat brain as a result of treatment with monoamine oxidase inhibiting antidepressants. Neuropharmacology. 1982 Apr;21(4):293–298. doi: 10.1016/0028-3908(82)90091-0. [DOI] [PubMed] [Google Scholar]
  6. Corn T. H., Thompson C., Checkley S. A. Effects of desipramine treatment upon central adrenoceptor function in normal subjects. Br J Psychiatry. 1984 Aug;145:139–145. doi: 10.1192/bjp.145.2.139. [DOI] [PubMed] [Google Scholar]
  7. Doogan D. P., Caillard V. Sertraline: a new antidepressant. J Clin Psychiatry. 1988 Aug;49 (Suppl):46–51. [PubMed] [Google Scholar]
  8. Durand D., Martin J. B., Brazeau P. Evidence for a role of alpha-adrenergic mechanisms in regulation of episodic growth hormone secretion in the rat. Endocrinology. 1977 Mar;100(3):722–728. doi: 10.1210/endo-100-3-722. [DOI] [PubMed] [Google Scholar]
  9. Edén S., Modigh K. Effects of apomorphine and clonidine on rat plasma growth hormone after pretreatment with reserpine and electroconvulsive shocks. Brain Res. 1977 Jul 1;129(2):379–384. doi: 10.1016/0006-8993(77)90020-8. [DOI] [PubMed] [Google Scholar]
  10. Einon D., Morgan M. J., Sahakian B. J. The development of intersession habituation and emergence in socially reared and isolated rats. Dev Psychobiol. 1975 Nov;8(6):553–559. doi: 10.1002/dev.420080613. [DOI] [PubMed] [Google Scholar]
  11. Eriksson E., Edén S., Modigh K. Up- and down- regulation of central postsynaptic alpha 2 receptors reflected in the growth hormone response to clonidine in reserpine-pretreated rats. Psychopharmacology (Berl) 1982;77(4):327–331. doi: 10.1007/BF00432764. [DOI] [PubMed] [Google Scholar]
  12. File S. E., Tucker J. C. Behavioral consequences of antidepressant treatment in rodents. Neurosci Biobehav Rev. 1986 Summer;10(2):123–134. doi: 10.1016/0149-7634(86)90023-0. [DOI] [PubMed] [Google Scholar]
  13. GLICK D., VONREDLICH D., LEVINE S. FLUOROMETRIC DETERMINATION OF CORTICOSTERONE AND CORTISOL IN 0.02-0.05 MILLILITERS OF PLASMA OR SUBMILLIGRAM SAMPLES OF ADRENAL TISSUE. Endocrinology. 1964 Apr;74:653–655. doi: 10.1210/endo-74-4-653. [DOI] [PubMed] [Google Scholar]
  14. Gentsch C., Lichtsteiner M., Kraeuchi K., Feer H. Different reaction patterns in individually and socially reared rats during exposures to novel environments. Behav Brain Res. 1982 Jan;4(1):45–54. doi: 10.1016/0166-4328(82)90163-2. [DOI] [PubMed] [Google Scholar]
  15. Gray J. A., Lalljee B. Sex differences in emotional behaviour in the rat: correlation between open-field defecation and active avoidance. Anim Behav. 1974 Nov;22(4):856–861. doi: 10.1016/0003-3472(74)90008-6. [DOI] [PubMed] [Google Scholar]
  16. Grealy M., O'Donnell J. M. Secretion of growth hormone elicited by intravenous desipramine in the conscious, unrestrained rat. Br J Pharmacol. 1991 Feb;102(2):369–372. doi: 10.1111/j.1476-5381.1991.tb12180.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Heal D. J., Prow M. R., Buckett W. R. Effects of antidepressant drugs and electroconvulsive shock on pre- and postsynaptic alpha 2-adrenoceptor function in the brain: rapid down-regulation by sibutramine hydrochloride. Psychopharmacology (Berl) 1991;103(2):251–257. doi: 10.1007/BF02244212. [DOI] [PubMed] [Google Scholar]
  18. Koe B. K., Weissman A., Welch W. M., Browne R. G. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin. J Pharmacol Exp Ther. 1983 Sep;226(3):686–700. [PubMed] [Google Scholar]
  19. Krulich L., Mayfield M. A., Steele M. K., McMillen B. A., McCann S. M., Koenig J. I. Differential effects of pharmacological manipulations of central alpha 1- and alpha 2-adrenergic receptors on the secretion of thyrotropin and growth hormone in male rats. Endocrinology. 1982 Mar;110(3):796–804. doi: 10.1210/endo-110-3-796. [DOI] [PubMed] [Google Scholar]
  20. Maj J., Klimek V., Nowak G. Antidepressant drugs given repeatedly increase binding to alpha 1-adrenoceptors in the rat cortex. Eur J Pharmacol. 1985 Dec 10;119(1-2):113–116. doi: 10.1016/0014-2999(85)90328-0. [DOI] [PubMed] [Google Scholar]
  21. Matsuda T., Kanda T., Seong Y. H., Baba A., Iwata H. p-chlorophenylalanine attenuates the pituitary-adrenocortical response to 5-HT1A receptor agonists in mice. Eur J Pharmacol. 1990 Jun 8;181(3):295–297. doi: 10.1016/0014-2999(90)90092-k. [DOI] [PubMed] [Google Scholar]
  22. McWilliam J. R., Meldrum B. S., Checkley S. A. Changes in the sensitivity of the central alpha- and beta-adrenergic systems during desmethylimipramine treatment as assessed by plasma growth hormone response in the baboon. Psychopharmacology (Berl) 1983;80(3):263–266. doi: 10.1007/BF00436166. [DOI] [PubMed] [Google Scholar]
  23. Menkes D. B., Aghajanian G. K., Gallager D. W. Chronic antidepressant treatment enhances agonist affinity of brain alpha 1-adrenoceptors. Eur J Pharmacol. 1983 Jan 28;87(1):35–41. doi: 10.1016/0014-2999(83)90047-x. [DOI] [PubMed] [Google Scholar]
  24. Mogilnicka E., Zazula M., Wedzony K. Functional supersensitivity to the alpha 1-adrenoceptor agonist after repeated treatment with antidepressant drugs is not conditioned by beta-down-regulation. Neuropharmacology. 1987 Oct;26(10):1457–1461. doi: 10.1016/0028-3908(87)90163-8. [DOI] [PubMed] [Google Scholar]
  25. Nowak G., Przegaliński E. Effect of repeated treatment with antidepressant drugs and electroconvulsive shock (ECS) on [3H] prazosin binding to different rat brain structures. J Neural Transm. 1988;71(1):57–64. doi: 10.1007/BF01259410. [DOI] [PubMed] [Google Scholar]
  26. Pilc A., Vetulani J. Depression by chronic electroconvulsive treatment of clonidine hypotherma and [3H]clonidine binding to rat cortical membranes. Eur J Pharmacol. 1982 May 7;80(1):109–113. doi: 10.1016/0014-2999(82)90184-4. [DOI] [PubMed] [Google Scholar]
  27. Płaźnik A., Kostowski W. Modification of behavioral response to intra-hippocampal injections of noradrenaline and adrenoceptor agonists by chronic treatment with desipramine and citalopram: functional aspects of adaptive receptor changes. Eur J Pharmacol. 1985 Nov 5;117(2):245–252. doi: 10.1016/0014-2999(85)90609-0. [DOI] [PubMed] [Google Scholar]
  28. Rehavi M., Ramot O., Yavetz B., Sokolovsky M. Amitriptyline: long-term treatment elevates alpha-adrenergic and muscarinic receptor binding in mouse brain. Brain Res. 1980 Aug 4;194(2):443–453. doi: 10.1016/0006-8993(80)91224-x. [DOI] [PubMed] [Google Scholar]
  29. Saphier D., Feldman S. Adrenoceptor specificity in the central regulation of adrenocortical secretion. Neuropharmacology. 1989 Nov;28(11):1231–1237. doi: 10.1016/0028-3908(89)90216-5. [DOI] [PubMed] [Google Scholar]
  30. Simonovic M., Gudelsky G. A., Meltzer H. Y. Effect of 8-hydroxy-2-(di-n-propylamino) tetralin on rat prolactin secretion. J Neural Transm. 1984;59(2):143–149. doi: 10.1007/BF01255412. [DOI] [PubMed] [Google Scholar]
  31. Tang S. W., Seeman P. Effect of antidepressant drugs on serotonergic and adrenergic receptors. Naunyn Schmiedebergs Arch Pharmacol. 1980 Apr;311(3):255–261. doi: 10.1007/BF00569405. [DOI] [PubMed] [Google Scholar]
  32. Tucker J. C., File S. E. The effects of tricyclic and 'atypical' antidepressants on spontaneous locomotor activity in rodents. Neurosci Biobehav Rev. 1986 Summer;10(2):115–121. doi: 10.1016/0149-7634(86)90022-9. [DOI] [PubMed] [Google Scholar]
  33. Vetulani J., Antkiewicz-Michaluk L., Rokosz-Pelc A. Chronic administration of antidepressant drugs increases the density of cortical [3H]prazosin binding sites in the rat. Brain Res. 1984 Sep 24;310(2):360–362. doi: 10.1016/0006-8993(84)90160-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES